Mood stabilisers for schizoaffective disorder
References
Additional references
Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. American Journal of Psychiatry 1994;151(12 Suppl):1‐36. [PUBMED: 7977902]
Bersudsky Y, Belmaker RH, Mishory A. Valnoctamide as a valproate substitute with low teratogenic potential: double‐blind controlled clinical trial. http://www.clinicaltrials.gov 2005.
Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, Boutitie F, Nony P, Haugh M, Mignot G. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'etude des Indices d'efficacite]. Therapie 1999;54(4):405‐11. [PUBMED: 10667106]
Brannon GE. Schizoaffective disorder. http://emedicine.medscape.com/article/294763‐overview (accessed 12 January 2011).
Chen G, Rajkowska G, Du F, Seraji‐Bozorgzad N, Manji HK. Enhancement of hippocampal neurogenesis by lithium. Journal of Neurochemistry 2000;75(4):1729‐34. [PUBMED: 10987856]
Deeks J. Issues in the selection for meta‐analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25‐28; Cape town. Cape Town: The Cochrane Collaboration, 2000.
Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623‐9.
Donner A, Klar N. Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971‐80.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34.
Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9.
Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. American Journal of Psychiatry 1998;155(1):12‐21. [PUBMED: 9433333]
Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(1):7‐10.
Gulliford MC. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876‐83.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jope RS. Anti‐bipolar therapy: mechanism of action of lithium. Molecular Psychiatry 1999;4(2):117‐28. [PUBMED: 10208444]
Kasanin J. The acute schizoaffective psychoses. 1933. American Journal of Psychiatry 1994;151(6 Suppl):144‐54. [PUBMED: 8192190]
Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986.
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2‐3):231‐8. [PUBMED: 15982856]
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry 2005;187:366‐71. [PUBMED: 16199797]
Leucht S, Kissling W, McGrath J. Lithium for schizophrenia. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003834.pub2]
Levinson DF, Umapathy C, Musthaq M. Treatment of schizoaffective disorder and schizophrenia with mood symptoms. American Journal of Psychiatry 1999;156(8):1138‐48. [PUBMED: 10450252]
Malhotra S. Acute and transient psychosis: A paradigmatic approach. Indian Journal of Psychiatry 2007;49(4):233‐43. [PUBMED: 20680134]
Marshall M, Lockwood A, Bradley C, Adams CE, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249‐52.
Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962;10:799‐812.
Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Bossuyt P, Chang S, Muti P, Jaeschke R, Guyatt GH. GRADE: assessing the quality of evidence for diagnostic recommendations. Evidence‐Based Medicine 2008;13(6):162‐3. [PUBMED: 19043023]
Stedman T. Stedman's Medical Dictionary. 28th Edition. Philadelphia and London: Lippincott Williams & Wilkins, 2006.
Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area‐wide and organistation‐based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1‐75.
Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El‐Sayeh H. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254‐7.
Young LT, Bakish D, Beaulieu S. The neurobiology of treatment response to antidepressants and mood stabilizing medications. Journal of Psychiatry & Neuroscience : JPN 2002;27(4):260‐5. [PUBMED: 12174735]
